Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme.
about
Evaluation of the impact of once weekly dulaglutide on patient-reported outcomes in Japanese patients with type 2 diabetes: comparisons with liraglutide, insulin glargine, and placebo in two randomized studies.Targeting orphan G protein-coupled receptors for the treatment of diabetes and its complications: C-peptide and GPR146.Dulaglutide in the treatment of adult type 2 diabetes: a perspective for primary care providers.Adherence to antihyperglycemic medications and glucagon-like peptide 1-receptor agonists in type 2 diabetes: clinical consequences and strategies for improvement.Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data.
P2860
Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Patient-reported outcome resul ...... III clinical trial programme.
@ast
Patient-reported outcome resul ...... III clinical trial programme.
@en
type
label
Patient-reported outcome resul ...... III clinical trial programme.
@ast
Patient-reported outcome resul ...... III clinical trial programme.
@en
prefLabel
Patient-reported outcome resul ...... III clinical trial programme.
@ast
Patient-reported outcome resul ...... III clinical trial programme.
@en
P2093
P2860
P356
P1476
Patient-reported outcome resul ...... III clinical trial programme.
@en
P2093
P2860
P304
P356
10.1111/DOM.12624
P577
2015-12-22T00:00:00Z